NASDAQ:CPIX Cumberland Pharmaceuticals (CPIX) Stock Forecast, Price & News $1.79 +0.01 (+0.56%) (As of 10/3/2023 ET) Add Compare Share Share Today's Range$1.63▼$1.8750-Day Range$1.43▼$2.3052-Week Range$1.43▼$2.91Volume8,978 shsAverage Volume21,394 shsMarket Capitalization$25.72 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaProfileChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media About Cumberland Pharmaceuticals (NASDAQ:CPIX) StockCumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Omeclamox-Pak for the treatment of Helicobacter pylori infection and duodenal ulcer disease; Vaprisol, an injection for treating euvolemic and hypervolemic hyponatremia; and Vibativ, an injection for the treatment of certain serious bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections. It also develops RediTrex injection for the treatment of active rheumatoid, juvenile idiopathic, and severe psoriatic arthritis, as well as disabling psoriasis. In addition, the company is developing ifetroban, a product candidate that is in phase II clinical trial for the treatment of aspirin-exacerbated respiratory disease, systemic sclerosis, and duchenne muscular dystrophy; and has completed phase II clinical trial for the treatment of hepatorenal syndrome and portal hypertension. Further, it develops a clinical program for the use of ifetroban to treat progressive fibrosing interstitial lung diseases; and a product candidate for cholesterol reducing agent to use in the hospital setting. The company was incorporated in 1999 and is headquartered in Nashville, Tennessee.Read More CPIX Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CPIX Stock News HeadlinesOctober 3, 2023 | msn.comCumberland Co. Schools partner with non-profit to fight child hungerOctober 3, 2023 | nj.comModri helps Cumberland top Highland to snap losing streak - Boys soccer recapOctober 4, 2023 | Behind the Markets (Ad)66,000% upside on tiny biotech?The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.October 3, 2023 | msn.comTruck with child inside shot in suspected road rage incident on busy Cumberland streetOctober 3, 2023 | msn.comMan accused of stealing $100k+ from father’s estate in Cumberland CountyOctober 3, 2023 | msn.comRetired fire chief sentenced for child pornography in Cumberland CountyOctober 3, 2023 | msn.comPolice: Cumberland County woman stabs boyfriend after accusing him of having affair with her motherOctober 3, 2023 | nj.comBoys soccer: Pilgrim Academy outpaces Cumberland Christian for 6th straight winOctober 4, 2023 | Behind the Markets (Ad)AI Creates New Cancer Drug - In Just 30 Days!On December 22, 2022, AI discovered a new treatment for multiple myeloma... in just 4 months... On March 19, 2023, AI discovered a new drug for liver cancer... in only 30 days... There's one small-cap at the center of it all. Bill Gates owns 7 million shares... Billionaire hedge-fund manager Steve Cohen owns 1.4 million shares...October 2, 2023 | sports.yahoo.comCumberland's win over Burrillville was one to remember and it wasn't hard to see whyOctober 2, 2023 | msn.comCumberland County libraries hold '31 Days of Love' supply drive for animal shelterSeptember 30, 2023 | msn.comDecomposed body found floating alongside dock at Lake CumberlandSeptember 30, 2023 | nj.comGirls soccer recap: Gabriella Piantadosi hat trick powers Egg Harbor over CumberlandSeptember 30, 2023 | news.yahoo.comCumberland gets two new firefighting vehiclesSeptember 30, 2023 | msn.comBody found at Lake CumberlandSeptember 30, 2023 | nj.comBoys soccer recap: Eli Croce scores pair to lead Delsea against CumberlandSeptember 29, 2023 | msn.comCumberland Valley’s Megan Fenton wins Mid-Penn golf title, Mechanicsburg tops girls team competitionSeptember 29, 2023 | msn.comPolice say 'IED' made of modified fireworks caused Cumberland Avenue explosionSeptember 29, 2023 | msn.comLast call for fun, food and farm animals at the 151st Cumberland County FairSeptember 29, 2023 | msn.comMan dies after hitting tree Cumberland CountySeptember 29, 2023 | msn.comWalking RI: Rare Atlantic white cedars still dot the trails of a Cumberland preserveSeptember 29, 2023 | msn.comDOJ: Cumberland County man indicted for producing, distributing child pornographySeptember 29, 2023 | nj.com10 most expensive homes sold in Cumberland County, Sept. 18-24September 29, 2023 | msn.comMan dies after hitting tree in Cumberland CountySeptember 29, 2023 | americanbankingnews.comCumberland Pharmaceuticals (NASDAQ:CPIX) Earns Hold Rating from Analysts at StockNews.comSeptember 29, 2023 | americanbankingnews.comCumberland Pharmaceuticals (NASDAQ:CPIX) Shares Pass Above Two Hundred Day Moving Average of $1.73September 28, 2023 | nj.comField hockey recap: Bobbi Jones goal lifts Highland over CumberlandSee More Headlines Receive CPIX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cumberland Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address CPIX Company Calendar Last Earnings8/08/2023Today10/03/2023Next Earnings (Estimated)11/14/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Pharmaceutical preparations Sub-IndustryPharmaceuticals SectorMedical Current SymbolNASDAQ:CPIX CUSIP23077010 CIK1087294 Webwww.cumberlandpharma.com Phone(615) 255-0068Fax615-255-0094Employees85Year Founded1999Profitability EPS (Most Recent Fiscal Year)($0.13) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-5,570,000.00 Net Margins-4.39% Pretax Margin-4.38% Return on Equity11.44% Return on Assets4.65% Debt Debt-to-Equity Ratio0.36 Current Ratio1.62 Quick Ratio1.21 Sales & Book Value Annual Sales$42.01 million Price / Sales0.61 Cash Flow$0.45 per share Price / Cash Flow4.00 Book Value$2.45 per share Price / Book0.73Miscellaneous Outstanding Shares14,370,000Free Float8,325,000Market Cap$25.72 million OptionableOptionable Beta0.24 Social Links 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?Get This Free Report Key ExecutivesMr. A. J. Kazimi MBA (Age 65)Founder, Chairman, Pres & CEO Comp: $897.5kMr. John Michael Hamm (Age 67)Chief Financial Officer Comp: $231.38kMr. James Lowrance Herman (Age 68)Exec. VP of National Accounts & Chief Compliance Officer Comp: $352.65kMs. Jean W. Marstiller (Age 73)Sr. VP of Admin. Services & Corp. Sec. Mr. Chris T. Bitterman (Age 58)VP of Sales & Marketing Mr. Adam S. Mostafa (Age 43)Managing Director Mr. Todd M. Anthony (Age 62)VP of Organizational Devel. Ms. Erin Smith GullSr. Corp. Relations AssociateMore ExecutivesKey CompetitorsAssembly BiosciencesNASDAQ:ASMBNektar TherapeuticsNASDAQ:NKTRRain OncologyNASDAQ:RAINTherapeuticsMDNASDAQ:TXMDBiora TherapeuticsNASDAQ:BIORView All CompetitorsInsiders & InstitutionsCitadel Advisors LLCSold 100 shares on 8/15/2023Ownership: 0.000%Renaissance Technologies LLCSold 10,920 shares on 8/11/2023Ownership: 3.881%BlackRock Inc.Sold 18,247 shares on 8/11/2023Ownership: 0.787%Dimensional Fund Advisors LPSold 101,743 shares on 8/9/2023Ownership: 3.511%B. Riley Wealth Advisors Inc.Bought 90,298 shares on 7/27/2023Ownership: 0.625%View All Insider TransactionsView All Institutional Transactions CPIX Stock - Frequently Asked Questions How have CPIX shares performed in 2023? Cumberland Pharmaceuticals' stock was trading at $2.25 at the beginning of the year. Since then, CPIX stock has decreased by 20.4% and is now trading at $1.79. View the best growth stocks for 2023 here. Are investors shorting Cumberland Pharmaceuticals? Cumberland Pharmaceuticals saw a increase in short interest during the month of September. As of September 15th, there was short interest totaling 21,300 shares, an increase of 13.3% from the August 31st total of 18,800 shares. Based on an average daily trading volume, of 20,500 shares, the days-to-cover ratio is presently 1.0 days. Approximately 0.3% of the shares of the company are short sold. View Cumberland Pharmaceuticals' Short Interest. When is Cumberland Pharmaceuticals' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 14th 2023. View our CPIX earnings forecast. How were Cumberland Pharmaceuticals' earnings last quarter? Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) released its quarterly earnings results on Tuesday, August, 8th. The specialty pharmaceutical company reported $0.15 EPS for the quarter. The specialty pharmaceutical company earned $10.89 million during the quarter. Cumberland Pharmaceuticals had a positive trailing twelve-month return on equity of 11.44% and a negative net margin of 4.39%. What is A. J. Kazimi's approval rating as Cumberland Pharmaceuticals' CEO? 9 employees have rated Cumberland Pharmaceuticals Chief Executive Officer A. J. Kazimi on Glassdoor.com. A. J. Kazimi has an approval rating of 9% among the company's employees. This puts A. J. Kazimi in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Cumberland Pharmaceuticals own? Based on aggregate information from My MarketBeat watchlists, some companies that other Cumberland Pharmaceuticals investors own include Fulcrum Therapeutics (FULC), VIVUS (VVUS), CymaBay Therapeutics (CBAY), Sorrento Therapeutics (SRNE), SCYNEXIS (SCYX), VBI Vaccines (VBIV), Akero Therapeutics (AKRO), Cerecor (CERC), Xeris Biopharma (XERS). What is Cumberland Pharmaceuticals' stock symbol? Cumberland Pharmaceuticals trades on the NASDAQ under the ticker symbol "CPIX." How do I buy shares of Cumberland Pharmaceuticals? Shares of CPIX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Cumberland Pharmaceuticals' stock price today? One share of CPIX stock can currently be purchased for approximately $1.79. How much money does Cumberland Pharmaceuticals make? Cumberland Pharmaceuticals (NASDAQ:CPIX) has a market capitalization of $25.72 million and generates $42.01 million in revenue each year. The specialty pharmaceutical company earns $-5,570,000.00 in net income (profit) each year or ($0.13) on an earnings per share basis. How can I contact Cumberland Pharmaceuticals? Cumberland Pharmaceuticals' mailing address is 2525 WEST END AVENUE SUITE 950, NASHVILLE TN, 37203. The official website for the company is www.cumberlandpharma.com. The specialty pharmaceutical company can be reached via phone at (615) 255-0068, via email at investors@cumberlandpharma.com, or via fax at 615-255-0094. This page (NASDAQ:CPIX) was last updated on 10/4/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cumberland Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.